Alniditan

Alniditan
Systematic (IUPAC) name
	N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
Clinical data
Pregnancy cat.	?
Legal status	?
Identifiers
CAS number	155428-00-5
ATC code	None
PubChem	CID 66004
IUPHAR ligand	117
ChemSpider	59396
UNII	B57Z82EOGE
KEGG	D02826
ChEMBL	CHEMBL88240
Chemical data
Formula	C17H26N4O
Mol. mass	302.41 g/mol
	SMILES C1CNC(=NC1)NCCCNCC2CCC3=CC=CC=C3O2;
	InChI InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1 ; Key:QVSXOXCYXPQXMF-OAHLLOKOSA-N ;
(what is this?) (verify);

Alniditan is a 5-HT_1D receptor agonist with migraine-preventative effects.^[1]

References [edit]

^ Leysen JE, Gommeren W, Heylen L, et al. (December 1996). "Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan". Mol. Pharmacol. 50 (6): 1567–80. PMID 8967979.